$VTEQ ~ VeriTeQ Corporation Expands Intellectual Property Portfolio With Patent Filing in Brazil - VeriTeQ Seeks Patent Protection for Its High-Temperature Q Inside Safety Technology Micro-Transponder in Brazil Due to Significant Breast Implant Market Opportunity
VeriTeQ Corporation
April 13, 2015 8:30 AM
GlobeNewswire
Related Quotes
VTEQ
0.0040
-27.27%
VeriTeQ Corporation
0.0040-0.0015(27.27%)
OTC MarketsTue, Apr 14, 2015 3:29 PM EDT
DELRAY BEACH, Fla., April 13, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ"
(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has expanded its intellectual property portfolio with a patent filing in Brazil for its high-temperature Q Inside Safety Technology micro-transponder.
Q Inside Safety Technology(TM) acts as an electronic serial number within implanted medical devices, and enables physicians and patients to access a secure, online database to retrieve implant-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the device manufacturer.
Q Inside Safety Technology is currently being used within Establishment Labs S.A. ("EL" Motiva Implant Matrix(R) breast implants. EL markets its CE marked breast implants throughout Europe, the United Kingdom, Latin America and Asia. According to the International Society of Aesthetic Plastic Surgeons, there were over 500,000 breast procedures performed in Brazil in 2013.
During the manufacturing process, breast implants are sterilized at high heat. The patent filing is intended to protect the high-temperature Q Inside Safety Technology transponders that can withstand high-temperature shocks and can maintain their physical and electrical characteristics following high-temperature exposure.
"Brazil is the second largest market in the world for breast procedures, so we believe it is important that we protect the advances we have made to Q Inside Safety Technology as the use of our technology grows throughout that country and elsewhere," stated Scott R. Silverman, Chairman and CEO of VeriTeQ.
About VeriTeQ
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit www.veriteqcorp.com.
http://finance.yahoo.com/news/veriteq-corpora...00685.html
CHART
VeriTeQ Corporation
April 13, 2015 8:30 AM
GlobeNewswire
Related Quotes
VTEQ
0.0040
-27.27%
VeriTeQ Corporation
0.0040-0.0015(27.27%)
OTC MarketsTue, Apr 14, 2015 3:29 PM EDT
DELRAY BEACH, Fla., April 13, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ"
(OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has expanded its intellectual property portfolio with a patent filing in Brazil for its high-temperature Q Inside Safety Technology micro-transponder. Q Inside Safety Technology(TM) acts as an electronic serial number within implanted medical devices, and enables physicians and patients to access a secure, online database to retrieve implant-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the device manufacturer.
Q Inside Safety Technology is currently being used within Establishment Labs S.A. ("EL"
Motiva Implant Matrix(R) breast implants. EL markets its CE marked breast implants throughout Europe, the United Kingdom, Latin America and Asia. According to the International Society of Aesthetic Plastic Surgeons, there were over 500,000 breast procedures performed in Brazil in 2013. During the manufacturing process, breast implants are sterilized at high heat. The patent filing is intended to protect the high-temperature Q Inside Safety Technology transponders that can withstand high-temperature shocks and can maintain their physical and electrical characteristics following high-temperature exposure.
"Brazil is the second largest market in the world for breast procedures, so we believe it is important that we protect the advances we have made to Q Inside Safety Technology as the use of our technology grows throughout that country and elsewhere," stated Scott R. Silverman, Chairman and CEO of VeriTeQ.
About VeriTeQ
VeriTeQ develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment. VeriTeQ offers the world's first FDA cleared RFID microchip technology that can be used to identify implantable medical devices, in vivo, on demand, at the point of care. VeriTeQ's dosimeters provide patient safety mechanisms while measuring and recording the dose of radiation delivered to a patient in real time. For more information on VeriTeQ, please visit www.veriteqcorp.com.
http://finance.yahoo.com/news/veriteq-corpora...00685.html
CHART
